Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitomycin C is a natural product-derived antineoplastic antibiotic and chemotherapeutic agent that functions primarily by forming covalent interstrand crosslinks in DNA after enzymatic reduction inside cells. This action blocks both replication and transcription processes essential for cell survival—making it highly effective against rapidly dividing tumor cells but also responsible for significant side effects due to lack of selectivity between normal proliferative tissues and tumors.
DNA crosslinking → inhibits replication/transcription → apoptosis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitomycin C.